Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_provenance.
- befree-20150227 importedOn "2015-02-27" NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_provenance.
- NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_assertion wasGeneratedBy ECO_0000203 NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_provenance.
- NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_assertion wasDerivedFrom befree-20150227 NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_provenance.
- NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_assertion SIO_000772 17496201 NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_provenance.
- NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_assertion evidence source_evidence_literature NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_provenance.
- NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_assertion description "[Dasatinib, a novel, oral, multitargeted kinase inhibitor of BCR-ABL and SRC family kinases, has previously induced responses in patients with imatinib-resistant or -intolerant Ph-positive ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_provenance.